Insights

Technology Integration SpringWorks' integration with Medisafe's technology presents an opportunity to leverage innovative JITI(TM) technology for targeted sales and educational content delivery to healthcare providers and patients.

Investor Interest Public recognition as the best performing pharma stock in 2025 signifies investor confidence, presenting a potential opportunity to attract new investors and partners interested in the biopharmaceutical sector.

Product Launches The recent launch of OGSIVEO tablets in enhanced blister packaging demonstrates a focus on patient convenience. This product enhancement could be used as a selling point to engage healthcare providers and improve patient adherence.

Strategic Partnerships Collaboration with Rappta Therapeutics for novel cancer treatments showcases a commitment to innovation. This partnership could lead to joint sales efforts targeting a wider range of cancers and rare diseases.

Industry Recognition Participation in prestigious events like the J.P. Morgan Healthcare Conference highlights SpringWorks' credibility within the industry. Utilize this industry recognition to build trust and secure strategic partnerships with key stakeholders.

SpringWorks Therapeutics Tech Stack

SpringWorks Therapeutics uses 8 technology products and services including SAS/STAT, Salesforce, Jupyter, and more. Explore SpringWorks Therapeutics's tech stack below.

  • SAS/STAT
    Advanced Analytics And Data Science
  • Salesforce
    Customer Relationship Management
  • Jupyter
    File Sharing
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Google Font API
    Font Scripts
  • jQuery
    Javascript Libraries
  • Salesforce Service Cloud
    Live Chat
  • C#
    Programming Languages

Media & News

SpringWorks Therapeutics's Email Address Formats

SpringWorks Therapeutics uses at least 1 format(s):
SpringWorks Therapeutics Email FormatsExamplePercentage
FLast@springworkstx.comJDoe@springworkstx.com
70%
First.Last@springworkstx.comJohn.Doe@springworkstx.com
16%
FirstLast@springworkstx.comJohnDoe@springworkstx.com
10%
Last@springworkstx.comDoe@springworkstx.com
4%

Frequently Asked Questions

Where is SpringWorks Therapeutics's headquarters located?

Minus sign iconPlus sign icon
SpringWorks Therapeutics's main headquarters is located at 100 Washington Blvd Stamford, Connecticut 06902 US. The company has employees across 2 continents, including North AmericaEurope.

What is SpringWorks Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact SpringWorks Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SpringWorks Therapeutics's stock symbol?

Minus sign iconPlus sign icon
SpringWorks Therapeutics is a publicly traded company; the company's stock symbol is SWTX.

What is SpringWorks Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
SpringWorks Therapeutics's official website is springworkstx.com and has social profiles on LinkedIn.

How much revenue does SpringWorks Therapeutics generate?

Minus sign iconPlus sign icon
As of June 2025, SpringWorks Therapeutics's annual revenue reached $75M.

What is SpringWorks Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
SpringWorks Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does SpringWorks Therapeutics have currently?

Minus sign iconPlus sign icon
As of June 2025, SpringWorks Therapeutics has approximately 411 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: S. I.Chief Executive Officer: S. I.Chief Medical Officer: J. C.. Explore SpringWorks Therapeutics's employee directory with LeadIQ.

What industry does SpringWorks Therapeutics belong to?

Minus sign iconPlus sign icon
SpringWorks Therapeutics operates in the Biotechnology Research industry.

What technology does SpringWorks Therapeutics use?

Minus sign iconPlus sign icon
SpringWorks Therapeutics's tech stack includes SAS/STATSalesforceJupyterTwitter Emoji (Twemoji)Google Font APIjQuerySalesforce Service CloudC#.

What is SpringWorks Therapeutics's email format?

Minus sign iconPlus sign icon
SpringWorks Therapeutics's email format typically follows the pattern of . Find more SpringWorks Therapeutics email formats with LeadIQ.

How much funding has SpringWorks Therapeutics raised to date?

Minus sign iconPlus sign icon
As of June 2025, SpringWorks Therapeutics has raised $228M in funding. The last funding round occurred on Apr 01, 2019 for $125M.

When was SpringWorks Therapeutics founded?

Minus sign iconPlus sign icon
SpringWorks Therapeutics was founded in 2017.
SpringWorks Therapeutics

SpringWorks Therapeutics

Biotechnology ResearchConnecticut, United States201-500 Employees

SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer.

Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors and hematological cancers, including clinical trials in rare tumor types and highly prevalent, genetically defined cancers.

Section iconCompany Overview

Headquarters
100 Washington Blvd Stamford, Connecticut 06902 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SWTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
201-500

Section iconFunding & Financials

  • $228M

    SpringWorks Therapeutics has raised a total of $228M of funding over 2 rounds. Their latest funding round was raised on Apr 01, 2019 in the amount of $125Mas a Series B.

  • $50M$100M

    SpringWorks Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $228M

    SpringWorks Therapeutics has raised a total of $228M of funding over 2 rounds. Their latest funding round was raised on Apr 01, 2019 in the amount of $125Mas a Series B.

  • $50M$100M

    SpringWorks Therapeutics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.